ClinicalTrials.Veeva

Menu

Hemodynamic Testing Strategies to Assess Pulmonary Hypertension in Heart Failure

Mount Sinai Hospital, Canada logo

Mount Sinai Hospital, Canada

Status

Enrolling

Conditions

Heart Failure

Treatments

Diagnostic Test: Right Heart Catheterization

Study type

Observational

Funder types

Other

Identifiers

NCT05672719
G21-0031553

Details and patient eligibility

About

The goal of this observational study is to learn about heart function and high lung blood pressure in patients with heart failure. The main question[s] it aims to answer are whether we can improve the ability to predict patients who will have complications after they receive treatment including heart transplant and left ventricular assist devices.

Full description

Prospective cohort study of patients with heart failure with reduced ejection fraction that are referred for diagnostic right heart catheterization as part of their evaluation for candidacy for advanced heart failure therapies.

Enrollment

74 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults age 18 years or older
  • Heart failure with reduced ejection fraction (<40%)
  • referred for RHC at our centre for evaluation of candidacy for advanced HF therapies.

Exclusion criteria

Severe valvular or complex congenital heart disease Short-term mechanical circulatory support for progressive cardiogenic shock (e.g. extracorporeal membrane oxygenation) Acute coronary syndrome or revascularization occurred within 7 days prior to the RHC.

Pregnant or breast-feeding Known hypersensitivity to sodium nitroprusside Advanced liver dysfunction Reduced capacity or inability to provide informed consent

Trial contacts and locations

1

Loading...

Central trial contact

Susanna Mak, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems